Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Head and Neck Cancer

  Free Subscription


Articles published in Dis Esophagus

Retrieve available abstracts of 185 articles:
HTML format
Text format



Single Articles


    December 2017
  1. KIM D, Min YW, Park JG, Lee H, et al
    Influence of esophagectomy on the gastroesophageal reflux in patients with esophageal cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  2. CHAO YK, Ku HY, Chen CY, Liu TW, et al
    Induction therapy before surgery improves survival in patients with clinical T3N0 esophageal cancer: a nationwide study in Taiwan.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  3. PARK SY, Kim DJ, Kang DR, Haam SJ, et al
    Learning curve for robotic esophagectomy and dissection of bilateral recurrent laryngeal nerve nodes for esophageal cancer.
    Dis Esophagus. 2017;30:1-9.
    PubMed     Text format     Abstract available


  4. KOSUMI K, Baba Y, Yamashita K, Ishimoto T, et al
    Monitoring sputum culture in resected esophageal cancer patients with preoperative treatment.
    Dis Esophagus. 2017;30:1-9.
    PubMed     Text format     Abstract available


    November 2017
  5. MAKINO T, Yamasaki M, Miyazaki Y, Wada N, et al
    Utility of initial induction chemotherapy with 5-fluorouracil, cisplatin, and docetaxel (DCF) for T4 esophageal cancer: a propensity score-matched analysis.
    Dis Esophagus. 2017 Nov 28. pii: 4670862. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. VISSER E, van Rossum PSN, van Veer H, Al-Naimi K, et al
    A structured training program for minimally invasive esophagectomy for esophageal cancer- a Delphi consensus study in Europe.
    Dis Esophagus. 2017 Nov 7. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. KIKUCHI D, Iizuka T, Hoteya S, Nomura K, et al
    Vascular density of superficial esophageal squamous cell carcinoma determined by direct observation of resected specimen using narrow band imaging with magnifying endoscopy.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  8. MODI RM, Mikhail S, Ciombor K, Perry KA, et al
    Outcomes of nutritional interventions to treat dysphagia in esophageal cancer: a population-based study.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  9. YAMASHITA K, Makino T, Yamasaki M, Tanaka K, et al
    Comparison of short-term outcomes between 2- and 3-field lymph node dissection for esophageal cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  10. TSAI FC, Ghorbani S, Greenwald BD, Jang S, et al
    Safety and efficacy of endoscopic spray cryotherapy for esophageal cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  11. TAKAHASHI K, Sato Y, Takeuchi M, Sato H, et al
    Changes in esophageal motility after endoscopic submucosal dissection for superficial esophageal cancer: a high-resolution manometry study.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  12. KOHLI DR, Schubert ML, Zfass AM, Shah TU, et al
    Performance characteristics of optical coherence tomography in assessment of Barrett's esophagus and esophageal cancer: systematic review.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  13. FUJIYOSHI T, Tajika M, Tanaka T, Ishihara M, et al
    Comparative evaluation of new and conventional classifications of magnifying endoscopy with narrow band imaging for invasion depth of superficial esophageal squamous cell carcinoma.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  14. CORAL RP, Constant-Neto M, Silva IS, Barros S, et al
    The influence of the transposed stomach through the posterior mediastinum on the respiratory forced expiratory volume and forced vital capacity in patients with resected esophageal cancer.
    Dis Esophagus. 2017;11:48-50.
    PubMed     Text format     Abstract available


    October 2017
  15. AL NATOUR RH, Catanzaro A, Zolotarevsky E, DeBenedet AT, et al
    Endoscopic therapy for Barrett's high grade dysplasia and intramucosal esophageal cancer is effective in community clinical practice by advanced endoscopists following multidisciplinary approach.
    Dis Esophagus. 2017 Oct 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. TIE H, He F, Shen J, Zhang B, et al
    Prolonged interval between neoadjuvant chemoradiotherapy and esophagectomy does not benefit the outcome in esophageal cancer: a systematic review and meta-analysis.
    Dis Esophagus. 2017 Oct 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. SUN SY, Zhao BQ, Wang J, Mo ZX, et al
    The clinical implications of mean platelet volume and mean platelet volume/platelet count ratio in locally advanced esophageal squamous cell carcinoma.
    Dis Esophagus. 2017 Oct 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. GRAHAM-WISENER L, Dempster M
    Peer advice giving from posttreatment to newly diagnosed esophageal cancer patients.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  19. OH TK, Jeon JH, Lee JM, Kim MS, et al
    Association of high-dose postoperative opioids with recurrence risk in esophageal squamous cell carcinoma: reinterpreting ERAS protocols for long-term oncologic surgery outcomes.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  20. BOHLE W, Kasper M, Zoller WG
    Prognostic relevance of serial endoscopic ultrasound after chemoradiation in esophageal cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  21. CHEN CY, Hsieh VC, Chang CH, Chen PR, et al
    Impacts of treatments on the quality of life among esophageal squamous cell carcinoma patients.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  22. FUJIWARA H, Shiozaki A, Konishi H, Kosuga T, et al
    Perioperative outcomes of single-port mediastinoscope-assisted transhiatal esophagectomy for thoracic esophageal cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  23. DAI Z, Lang W, Yang H, Tian J, et al
    Validation of EORTC QLQ-OES18 for Chinese patients with esophageal cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


    September 2017
  24. LI QW, Qiu B, Wang B, Wang DL, et al
    Prediction of pathologic responders to neoadjuvant chemoradiotherapy by diffusion-weighted magnetic resonance imaging in locally advanced esophageal squamous cell carcinoma: a prospective study.
    Dis Esophagus. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  25. DEPYPERE L, Moons J, Lerut T, De Hertogh G, et al
    Prognostic value of the circumferential resection margin and its definitions in esophageal cancer patients after neoadjuvant chemoradiotherapy.
    Dis Esophagus. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  26. OKAMURA A, Watanabe M, Mine S, Kurogochi T, et al
    Failure of neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  27. SHEN S, Araujo JL, Altorki NK, Sonett JR, et al
    Variation by stage in the effects of prediagnosis weight loss on mortality in a prospective cohort of esophageal cancer patients.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  28. WELCH G, Ross HJ, Patel NP, Jaroszewski DE, et al
    Incidence of brain metastasis from esophageal cancer.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Text format     Abstract available


  29. TSANG JS, Tong DKH, Lam KO, Law BTT, et al
    Appropriate timing for surgery after neoadjuvant chemoradiation for esophageal cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  30. SONG T, Du D, Zhang X, Fang M, et al
    Comparative study of radiotherapy plus erlotinib versus chemoradiotherapy for elderly patients with esophageal cancer: a propensity score-matched analysis.
    Dis Esophagus. 2017;30:1-10.
    PubMed     Text format     Abstract available


  31. MA Z, Chen C, Tang P, Zhang H, et al
    BNIP3 induces apoptosis and protective autophagy under hypoxia in esophageal squamous cell carcinoma cell lines: BNIP3 regulates cell death.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


    August 2017
  32. HUDDY JR, Huddy FMS, Markar SR, Tucker O, et al
    Nutritional optimization during neoadjuvant therapy prior to surgical resection of esophageal cancer - A narrative review.
    Dis Esophagus. 2017 Aug 30. doi: 10.1093.
    PubMed     Text format     Abstract available


  33. YAP WK, Chang YC, Tseng CK, Hsieh CH, et al
    Predictive value of nodal maximum standardized uptake value of pretreatment [18F]fluorodeoxyglucose positron emission tomography imaging in patients with esophageal cancer.
    Dis Esophagus. 2017;30:1-10.
    PubMed     Text format     Abstract available


  34. NAKATANI M, Migita K, Matsumoto S, Wakatsuki K, et al
    Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  35. GANNON JA, Guinan EM, Doyle SL, Beddy P, et al
    Reduced fitness and physical functioning are long-term sequelae after curative treatment for esophageal cancer: a matched control study.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


    July 2017
  36. SANFORD NN, Catalano PJ, Enzinger PC, King BL, et al
    A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  37. CHEN Y, Hao D, Wu X, Xing W, et al
    Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  38. HAISLEY KR, Hart KD, Nabavizadeh N, Bensch KG, et al
    Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


    June 2017
  39. QIAN X, Tan C, Yang B, Wang F, et al
    Astaxanthin increases radiosensitivity in esophageal squamous cell carcinoma through inducing apoptosis and G2/M arrest.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  40. SUN L, Cao J, Guo C, Burnett J, et al
    Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  41. UNO K, Koike T, Kusaka G, Takahashi Y, et al
    Risk of metachronous recurrence after endoscopic submucosal dissection of esophageal squamous cell carcinoma.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


    May 2017
  42. HE Y, Liu J, Zhao Z, Zhao H, et al
    Bioinformatics analysis of gene expression profiles of esophageal squamous cell carcinoma.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  43. CHEN HL, Shen WQ, Liu K
    Radioactive self-expanding stents for palliative management of unresectable esophageal cancer: a systematic review and meta-analysis.
    Dis Esophagus. 2017;30:1-16.
    PubMed     Text format     Abstract available


  44. AKIYAMA Y, Iwaya T, Endo F, Shioi Y, et al
    Stability of cervical esophagogastrostomy via hand-sewn anastomosis after esophagectomy for esophageal cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  45. ZHANG H, Chen L, Geng Y, Zheng Y, et al
    Modified anastomotic technique for thoracolaparoscopic Ivor-Lewis esophagectomy: early outcomes and technical details.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  46. WIGHTMAN SC, Posner MC, Patti MG, Ganai S, et al
    Extremes of body mass index and postoperative complications after esophagectomy.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Text format     Abstract available


    April 2017
  47. ZHANG Z, Zhang H
    Impact of neoadjuvant chemotherapy and chemoradiotherapy on postoperative cardiopulmonary complications in patients with esophageal cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  48. LACERDA CF, Cruvinel-Carloni A, de Oliveira AT, Scapulatempo-Neto C, et al
    Mutational profile of TP53 in esophageal squamous cell carcinoma associated with chagasic megaesophagus.
    Dis Esophagus. 2017;30:1-9.
    PubMed     Text format     Abstract available


  49. DE B, Rhome R, Doucette J, Buckstein M, et al
    Dose escalation of definitive radiation is not associated with improved survival for cervical esophageal cancer: a National Cancer Data Base (NCDB) analysis.
    Dis Esophagus. 2017;30:1-10.
    PubMed     Text format     Abstract available


  50. VAN RULER MA, Peters FP, Slingerland M, Fiocco M, et al
    Clinical outcomes of definitive chemoradiotherapy using carboplatin and paclitaxel in esophageal cancer.
    Dis Esophagus. 2017;30:1-9.
    PubMed     Text format     Abstract available


  51. RATNASINGHAM K, Stroud L, Knight J, Preston SR, et al
    Analysis of 11 years of clinical negligence claims in esophagogastric cancer in England.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  52. DUAN J, Deng T, Ying G, Zhang H, et al
    Prognostic significance of the T2 substage in patients with esophageal squamous cell carcinoma.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  53. POWELL AG, Hughes DL, Brown J, Larsen M, et al
    Esophageal cancer's 100 most influential manuscripts: a bibliometric analysis.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  54. GIACOPUZZI S, Weindelmayer J, Treppiedi E, Bencivenga M, et al
    Enhanced recovery after surgery protocol in patients undergoing esophagectomy for cancer: a single center experience.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Text format     Abstract available


    March 2017
  55. MA M, Shroff S, Feldman M, DeMarshall M, et al
    Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  56. KOJIMA K, Yamashita K, Ushiku H, Katoh H, et al
    The clinical significance of cysteine dioxygenase type 1 methylation in Barrett esophagus adenocarcinoma.
    Dis Esophagus. 2017;30:1-9.
    PubMed     Text format     Abstract available


    February 2017
  57. MARSHALL-WEBB M, Bright T, Price T, Thompson SK, et al
    Venous thromboembolism in patients with esophageal or gastric cancer undergoing neoadjuvant chemotherapy.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  58. WEINER JP, Shao M, Schwartz D, Wong A, et al
    Patterns of care and survival outcomes in the treatment of esophageal melanoma.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Text format     Abstract available


  59. WONG AT, Shao M, Rineer J, Osborn V, et al
    Treatment and survival outcomes of small cell carcinoma of the esophagus: an analysis of the National Cancer Data Base.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  60. YANG H, Feng C, Cai BN, Yang J, et al
    Comparison of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, and volumetric-modulated arc therapy in the treatment of cervical esophageal carcinoma.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  61. MURPHY CC, Yang YC, Shaheen NJ, Hofstetter WL, et al
    An age-period-cohort analysis of obesity and incident esophageal adenocarcinoma among white males.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  62. MALIK V, Johnston C, O'Toole D, Lucey J, et al
    Metabolic tumor volume provides complementary prognostic information to EUS staging in esophageal and junctional cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  63. ROSMOLEN WD, Nieuwkerk PT, Pouw RE, van Berge Henegouwen MI, et al
    Quality of life and fear of cancer recurrence after endoscopic treatment for early Barrett's neoplasia: a prospective study.
    Dis Esophagus. 2017;30:1-9.
    PubMed     Text format     Abstract available


  64. LINDNER K, Lubbe L, Muller AK, Palmes D, et al
    Potential risk factors and outcomes of fistulas between the upper intestinal tract and the airway following Ivor-Lewis esophagectomy.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  65. KJAER DW, Nassar M, Jensen LS, Svendsen LB, et al
    A bridging stent to surgery in patients with esophageal and gastroesophageal junction cancer has a dramatic negative impact on patient survival: A retrospective cohort study through data acquired from a prospectively maintained national database.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  66. MANNER H, Wetzka J, May A, Pauthner M, et al
    Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b sm2-3): the frequency of lymph-node metastasis depends on macroscopic and histological risk patterns.
    Dis Esophagus. 2017;30:1-11.
    PubMed     Text format     Abstract available


  67. CHEN H, Ni Z, Jing D, He L, et al
    Novel stent in the palliation of malignant esophageal strictures: a retrospective study.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  68. OJIMA T, Nakamori M, Nakamura M, Katsuda M, et al
    Phase I/II study of divided-dose docetaxel, cisplatin and fluorouracil for patients with recurrent or metastatic squamous cell carcinoma of the esophagus.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


    January 2017
  69. MATSUMOTO A, Watanabe M, Mine S, Nishida K, et al
    Comparison of synchronous versus staged surgeries for patients with synchronous double cancers of the esophagus and head-and-neck.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Text format     Abstract available


  70. LINDER G, Hedberg J, Bjorck M, Sundbom M, et al
    Perfusion of the gastric conduit during esophagectomy.
    Dis Esophagus. 2017;30:143-149.
    PubMed     Text format     Abstract available


  71. ZHANG H, Chen L, Geng Y, Zheng Y, et al
    Modified anastomotic technique for thoracolaparoscopic Ivor Lewis esophagectomy: early outcomes and technical details.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  72. DEPYPERE L, Lerut T, Moons J, Coosemans W, et al
    Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  73. JANUSZEWICZ W, Kaminski MF, Wieszczy P, Wronska E, et al
    Adenocarcinoma risk in patients registered with Polish Barrett's Oesophagus Registry.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Text format     Abstract available


  74. GOENSE L, van Rossum PS, Tromp M, Joore HC, et al
    Intraoperative and postoperative risk factors for anastomotic leakage and pneumonia after esophagectomy for cancer.
    Dis Esophagus. 2017;30:1-10.
    PubMed     Text format     Abstract available


  75. SALEM AI, Thau MR, Strom TJ, Abbott AM, et al
    Effect of body mass index on operative outcome after robotic-assisted Ivor-Lewis esophagectomy: retrospective analysis of 129 cases at a single high-volume tertiary care center.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  76. WU HL, Guan BX, Liu B, Wang HJ, et al
    The intrapapillary capillary loop (IPCL) changes in superficial esophageal lesions.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  77. HAVERKAMP L, Seesing MF, Ruurda JP, Boone J, et al
    Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  78. PANTHAM G, Ganesan S, Einstadter D, Jin G, et al
    Assessment of the incidence of squamous cell papilloma of the esophagus and the presence of high-risk human papilloma virus.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  79. ZHAO J, Han Y, Lei J, Zhou Y, et al
    Simultaneous esophagectomy and off-pump coronary artery bypass grafting: a practicable approach with good survival.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  80. VAN ROSSUM PS, Haverkamp L, Carvello M, Ruurda JP, et al
    Management and outcome of cervical versus intrathoracic manifestation of cervical anastomotic leakage after transthoracic esophagectomy for cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  81. VAN EGMOND MA, van der Schaaf M, Klinkenbijl JH, Engelbert RH, et al
    Preoperative functional status is not associated with postoperative surgical complications in low risk patients undergoing esophagectomy.
    Dis Esophagus. 2017;30:1-7.
    PubMed     Text format     Abstract available


  82. PARK A, Lee JH, Park A, Jung YH, et al
    Prevalence rate and clinical characteristics of esophageal ectopic sebaceous glands in asymptomatic health screen examinees.
    Dis Esophagus. 2017;30:1-5.
    PubMed     Text format     Abstract available


  83. D'JOURNO XB, Berbis J, Jougon J, Brichon PY, et al
    External validation of a risk score in the prediction of the mortality after esophagectomy for cancer.
    Dis Esophagus. 2017;30:1-8.
    PubMed     Text format     Abstract available


  84. FUCHS HF, Harnsberger CR, Broderick RC, Chang DC, et al
    Simple preoperative risk scale accurately predicts perioperative mortality following esophagectomy for malignancy.
    Dis Esophagus. 2017;30:1-6.
    PubMed     Text format     Abstract available


    November 2016
  85. FANG HY, Chao YK, Chang HK, Tseng CK, et al
    Survival outcomes of consolidation chemoradiotherapy in esophageal cancer patients who achieve clinical complete response but refuse surgery after neoadjuvant chemoradiotherapy.
    Dis Esophagus. 2016 Nov 23. doi: 10.1111/dote.12515.
    PubMed     Text format     Abstract available


  86. ZHANG F, Wang Y, Wang ZQ, Sun P, et al
    Efficacy and safety of cisplatin-based versus nedaplatin-based regimens for the treatment of metastatic/recurrent and advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis.
    Dis Esophagus. 2016 Nov 21. doi: 10.1111/dote.12490.
    PubMed     Text format     Abstract available


  87. MIKHAIL S, Wei L, Salem ME, Bekaii-Saab T, et al
    Outcomes of definitive chemoradiation in patients with esophageal cancer.
    Dis Esophagus. 2016 Nov 21. doi: 10.1111/dote.12506.
    PubMed     Text format     Abstract available


  88. LIN Y, Shen LY, Fu H, Dong B, et al
    P21, COX-2, and E-cadherin are potential prognostic factors for esophageal squamous cell carcinoma.
    Dis Esophagus. 2016 Nov 21. doi: 10.1111/dote.12522.
    PubMed     Text format     Abstract available


  89. CHAO YK, Chang HK, Tseng CK, Liu YH, et al
    Development of a nomogram for the prediction of pathological complete response after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.
    Dis Esophagus. 2016 Nov 21. doi: 10.1111/dote.12519.
    PubMed     Text format     Abstract available


  90. LI J, Tang Y, Huang L, Yu Q, et al
    A high number of stromal tumor-infiltrating lymphocytes is a favorable independent prognostic factor in M0 (stages I-III) esophageal squamous cell carcinoma.
    Dis Esophagus. 2016 Nov 21. doi: 10.1111/dote.12518.
    PubMed     Text format     Abstract available


  91. BABA Y, Saeki H, Nakashima Y, Oki E, et al
    Review of chemotherapeutic approaches for operable and inoperable esophageal squamous cell carcinoma.
    Dis Esophagus. 2016 Nov 21. doi: 10.1111/dote.12521.
    PubMed     Text format     Abstract available


  92. GUINAN EM, Dowds J, Donohoe C, Reynolds JV, et al
    The physiotherapist and the esophageal cancer patient: from prehabilitation to rehabilitation.
    Dis Esophagus. 2016 Nov 9. doi: 10.1111/dote.12514.
    PubMed     Text format     Abstract available


  93. SHUTO K, Kono T, Akutsu Y, Uesato M, et al
    Naso-esophageal extraluminal drainage for postoperative anastomotic leak after thoracic esophagectomy for patients with esophageal cancer.
    Dis Esophagus. 2016 Nov 9. doi: 10.1111/dote.12492.
    PubMed     Text format     Abstract available


  94. TAKEBAYASHI K, Tsubosa Y, Matsuda S, Kawamorita K, et al
    Comparison of curative surgery and definitive chemoradiotherapy as initial treatment for patients with cervical esophageal cancer.
    Dis Esophagus. 2016 Nov 9. doi: 10.1111/dote.12502.
    PubMed     Text format     Abstract available


  95. NIE L, Wu HY, Shen YH, Fan XS, et al
    Esophageal submucosal gland duct adenoma: a clinicopathological and immunohistochemical study with a review of the literature.
    Dis Esophagus. 2016;29:1048-1053.
    PubMed     Text format     Abstract available


  96. ZHANG Z, Ai B, Liao Y, Liu L, et al
    Novel methylene blue staining technique for localizing small esophageal leiomyomas during thoracoscopic enucleation.
    Dis Esophagus. 2016;29:1043-1047.
    PubMed     Text format     Abstract available


  97. STIEKEMA J, Cats A, Boot H, Langers AM, et al
    Biobanking of fresh-frozen endoscopic biopsy specimens from esophageal adenocarcinoma.
    Dis Esophagus. 2016;29:1100-1106.
    PubMed     Text format     Abstract available


  98. NOSHIRO H, Yoda Y, Hiraki M, Kono H, et al
    Survival outcomes of 220 consecutive patients with three-staged thoracoscopic esophagectomy.
    Dis Esophagus. 2016;29:1090-1099.
    PubMed     Text format     Abstract available


  99. ACAR T, Savas R, Kocacelebi K, Ersoz G, et al
    Squamous cell carcinoma arising from a Zenker's diverticulum: contribution of FDG-PET/CT to the diagnosis.
    Dis Esophagus. 2016;29:1170-1171.
    PubMed     Text format    


  100. SCARPA M, Cavallin F, Saadeh LM, Pinto E, et al
    Hybrid minimally invasive esophagectomy for cancer: impact on postoperative inflammatory and nutritional status.
    Dis Esophagus. 2016;29:1064-1070.
    PubMed     Text format     Abstract available


  101. ZHAO X, Wang X, Li A, Sheng J, et al
    Endoscopic resection of a giant esophageal lipoma: a case report.
    Dis Esophagus. 2016;29:1167-1169.
    PubMed     Text format    


  102. NAGAI K, Tsujii Y, Matsui T, Yoshii S, et al
    Esophagogastric junctional adenocarcinoma originating from endoscopically unrecognizable Barrett's epithelium.
    Dis Esophagus. 2016;29:1164-1166.
    PubMed     Text format    


  103. RICE TW, Ishwaran H, Hofstetter WL, Kelsen DP, et al
    Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.
    Dis Esophagus. 2016;29:897-905.
    PubMed     Text format     Abstract available


  104. RICE TW, Ishwaran H, Blackstone EH, Hofstetter WL, et al
    Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.
    Dis Esophagus. 2016;29:913-919.
    PubMed     Text format     Abstract available


  105. RICE TW, Ishwaran H, Kelsen DP, Hofstetter WL, et al
    Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.
    Dis Esophagus. 2016;29:906-912.
    PubMed     Text format     Abstract available


  106. SHAH IA, Bhat GA, Mehta P, Lone MM, et al
    Genotypes of CYP1A1, SULT1A1 and SULT1A2 and risk of squamous cell carcinoma of esophagus: outcome of a case-control study from Kashmir, India.
    Dis Esophagus. 2016;29:937-943.
    PubMed     Text format     Abstract available


  107. ZHAN C, Yan L, Wang L, Jiang W, et al
    Landscape of expression profiles in esophageal carcinoma by The Cancer Genome Atlas data.
    Dis Esophagus. 2016;29:920-928.
    PubMed     Text format     Abstract available


    October 2016
  108. JEENE PM, Versteijne E, van Berge Henegouwen MI, Bergmann JJ, et al
    Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.
    Dis Esophagus. 2016 Oct 21. doi: 10.1111/dote.12539.
    PubMed     Text format     Abstract available


  109. TAN JT, Yang Y, Mao NQ, Liu DS, et al
    Effect of neoadjuvant chemoradiotherapy on perioperative immune function of patients with locally advanced esophageal cancer.
    Dis Esophagus. 2016 Oct 21. doi: 10.1111/dote.12486.
    PubMed     Text format     Abstract available


  110. RICE TW, Apperson-Hansen C, DiPaola LM, Semple ME, et al
    Worldwide Esophageal Cancer Collaboration: clinical staging data.
    Dis Esophagus. 2016;29:707-714.
    PubMed     Text format     Abstract available


  111. RICE TW, Lerut TE, Orringer MB, Chen LQ, et al
    Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data.
    Dis Esophagus. 2016;29:715-723.
    PubMed     Text format     Abstract available


  112. RICE TW, Chen LQ, Hofstetter WL, Smithers BM, et al
    Worldwide Esophageal Cancer Collaboration: pathologic staging data.
    Dis Esophagus. 2016;29:724-733.
    PubMed     Text format     Abstract available


  113. ZHANG L, Zhao W, Zheng Z, Wang T, et al
    Hydrogen sulfide synthesis enzymes reduced in lower esophageal sphincter of patients with achalasia.
    Dis Esophagus. 2016;29:801-806.
    PubMed     Text format     Abstract available


  114. LEE HW, Kwon J, Kang MC, Noh MK, et al
    Overexpression of HSP47 in esophageal squamous cell carcinoma: clinical implications and functional analysis.
    Dis Esophagus. 2016;29:848-855.
    PubMed     Text format     Abstract available


  115. CHEN JY, Yang H, Wen J, Luo KJ, et al
    Association between positive murine double minute 2 expression and clinicopathological characteristics of esophageal squamous cell carcinoma: a meta-analysis.
    Dis Esophagus. 2016;29:856-863.
    PubMed     Text format     Abstract available


  116. LEE DS, Ahn YC, Eom DW, Lee SJ, et al
    Primary esophageal mucosa-associated lymphoid tissue lymphoma diagnosed by using stacked forceps biopsy.
    Dis Esophagus. 2016;29:887-890.
    PubMed     Text format     Abstract available


  117. RATUAPLI SK, Thind K, Fleischer DE, Shiff AD, et al
    Esophageal leukoplakia: a rare cause of white patches in esophagus with malignant potential.
    Dis Esophagus. 2016;29:885.
    PubMed     Text format    


    September 2016
  118. KANEMURA T, Makino T, Miyazaki Y, Takahashi T, et al
    Distribution patterns of metastases in recurrent laryngeal nerve lymph nodes in patients with squamous cell esophageal cancer.
    Dis Esophagus. 2016 Sep 15. doi: 10.1111/dote.12527.
    PubMed     Text format     Abstract available


  119. USHIKU H, Yamashita K, Katoh H, Ema A, et al
    Promoter DNA methylation of CDO1 gene and its clinical significance in esophageal squamous cell carcinoma.
    Dis Esophagus. 2016 Sep 15. doi: 10.1111/dote.12496.
    PubMed     Text format     Abstract available


  120. RODRIGUES-PINTO E, Pereira P, Coelho R, Andrade P, et al
    Outcome and risk factors assessment for adverse events in advanced esophageal cancer patients after self-expanding metal stents placement.
    Dis Esophagus. 2016 Sep 15. doi: 10.1111/dote.12467.
    PubMed     Text format     Abstract available


    August 2016
  121. NIWA Y, Koike M, Fujimoto Y, Oya H, et al
    Salvage pharyngolaryngectomy with total esophagectomy following definitive chemoradiotherapy.
    Dis Esophagus. 2016;29:598-602.
    PubMed     Text format     Abstract available


  122. KUNZLI HT, van Berge Henegouwen M, Gisbertz S, Seldenrijk C, et al
    Thoracolaparoscopic dissection of esophageal lymph nodes without esophagectomy is feasible in human cadavers and safe in a porcine survival study.
    Dis Esophagus. 2016;29:649-55.
    PubMed     Text format     Abstract available


  123. TSOU YK, Chuang WY, Liu CY, Ohata K, et al
    Learning curve for endoscopic submucosal dissection of esophageal neoplasms.
    Dis Esophagus. 2016;29:544-50.
    PubMed     Text format     Abstract available


  124. NABAVIZADEH N, Shukla R, Elliott DA, Mitin T, et al
    Preoperative carboplatin and paclitaxel-based chemoradiotherapy for esophageal carcinoma: results of a modified CROSS regimen utilizing radiation doses greater than 41.4 Gy.
    Dis Esophagus. 2016;29:614-20.
    PubMed     Text format     Abstract available


  125. BRANKLEY SM, Halling KC, Jenkins SM, Timmer MR, et al
    Fluorescence in situ hybridization identifies high risk Barrett's patients likely to develop esophageal adenocarcinoma.
    Dis Esophagus. 2016;29:513-9.
    PubMed     Text format     Abstract available


  126. OYA H, Kanda M, Koike M, Iwata N, et al
    Detection of serum melanoma-associated antigen D4 in patients with squamous cell carcinoma of the esophagus.
    Dis Esophagus. 2016;29:663-9.
    PubMed     Text format     Abstract available


  127. SWAGER A, Boerwinkel DF, de Bruin DM, Weusten BL, et al
    Volumetric laser endomicroscopy in Barrett's esophagus: a feasibility study on histological correlation.
    Dis Esophagus. 2016;29:505-12.
    PubMed     Text format     Abstract available


  128. CONG QX, Zhang H, Sun SX, Li HF, et al
    Pilot study special AT-rich sequence-binding protein 1 investigating as a potential biomarker for esophageal squamous cell carcinoma.
    Dis Esophagus. 2016;29:621-6.
    PubMed     Text format     Abstract available


  129. MINEGAKI T, Fukushima S, Morioka C, Takanashi H, et al
    Effects of bisphosphonates on human esophageal squamous cell carcinoma cell survival.
    Dis Esophagus. 2016;29:656-62.
    PubMed     Text format     Abstract available


  130. SCARPA M, Filip B, Cavallin F, Alfieri R, et al
    Esophagectomy in elderly patients: which is the best prognostic score?
    Dis Esophagus. 2016;29:589-97.
    PubMed     Text format     Abstract available


  131. DAY RW, Jaroszewski D, Chang YH, Ross HJ, et al
    Incidence and impact of postoperative atrial fibrillation after minimally invasive esophagectomy.
    Dis Esophagus. 2016;29:583-8.
    PubMed     Text format     Abstract available


    July 2016
  132. HAVERKAMP L, Parry K, van Berge Henegouwen MI, van Laarhoven HW, et al
    Esophageal and Gastric Cancer Pearl: a nationwide clinical biobanking project in the Netherlands.
    Dis Esophagus. 2016;29:435-41.
    PubMed     Text format     Abstract available


  133. SUNDE B, Ericson J, Kumagai K, Lundell L, et al
    Relief of dysphagia during neoadjuvant treatment for cancer of the esophagus or gastroesophageal junction.
    Dis Esophagus. 2016;29:442-7.
    PubMed     Text format     Abstract available


  134. WANG BJ, Zhang B, Yan SS, Li ZC, et al
    Hormonal and reproductive factors and risk of esophageal cancer in women: a meta-analysis.
    Dis Esophagus. 2016;29:448-54.
    PubMed     Text format     Abstract available


  135. MORI K, Yamagata Y, Aikou S, Nishida M, et al
    Short-term outcomes of robotic radical esophagectomy for esophageal cancer by a nontransthoracic approach compared with conventional transthoracic surgery.
    Dis Esophagus. 2016;29:429-34.
    PubMed     Text format     Abstract available


  136. WAN J, Wu W, Che Y, Kang N, et al
    Insights into the potential use of microRNAs as a novel class of biomarkers in esophageal cancer.
    Dis Esophagus. 2016;29:412-20.
    PubMed     Text format     Abstract available


  137. LI B, Tang SP, Wang KZ
    Esophagus cancer and occupational exposure to asbestos: results from a meta-analysis of epidemiology studies.
    Dis Esophagus. 2016;29:421-8.
    PubMed     Text format     Abstract available


  138. JI WH, Jiang YH, Ji YL, Li B, et al
    Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
    Dis Esophagus. 2016;29:403-11.
    PubMed     Text format     Abstract available


    June 2016
  139. TAN D, Wu Y, Hu L, He P, et al
    Long noncoding RNA H19 is up-regulated in esophageal squamous cell carcinoma and promotes cell proliferation and metastasis.
    Dis Esophagus. 2016 Jun 1. doi: 10.1111/dote.12481.
    PubMed     Text format     Abstract available


    May 2016
  140. PENG J, Cai J, Niu ZX, Chen LQ, et al
    Early enteral nutrition compared with parenteral nutrition for esophageal cancer patients after esophagectomy: a meta-analysis.
    Dis Esophagus. 2016;29:333-41.
    PubMed     Text format     Abstract available


  141. PARK SY, Kim DJ, Yu WS, Jung HS, et al
    Robot-assisted thoracoscopic esophagectomy with extensive mediastinal lymphadenectomy: experience with 114 consecutive patients with intrathoracic esophageal cancer.
    Dis Esophagus. 2016;29:326-32.
    PubMed     Text format     Abstract available


  142. HARADA K, Mine S, Yamada K, Shigaki H, et al
    Long-term outcome of esophagectomy for primary malignant melanoma of the esophagus: a single-institute retrospective analysis.
    Dis Esophagus. 2016;29:314-9.
    PubMed     Text format     Abstract available


  143. DOLAN JP, Kaur T, Diggs BS, Luna RA, et al
    Significant understaging is seen in clinically staged T2N0 esophageal cancer patients undergoing esophagectomy.
    Dis Esophagus. 2016;29:320-5.
    PubMed     Text format     Abstract available


  144. SUNPAWERAVONG S, Sunpaweravong P, Sathitruangsak C, Mai S, et al
    Three-dimensional telomere architecture of esophageal squamous cell carcinoma: comparison of tumor and normal epithelial cells.
    Dis Esophagus. 2016;29:307-13.
    PubMed     Text format     Abstract available


    April 2016
  145. ZU Y, Ping W, Deng T, Zhang N, et al
    Lipopolysaccharide-induced toll-like receptor 4 signaling in esophageal squamous cell carcinoma promotes tumor proliferation and regulates inflammatory cytokines expression.
    Dis Esophagus. 2016 Apr 7. doi: 10.1111/dote.12466.
    PubMed     Text format     Abstract available


  146. QU Y, Zhang S, Cui L, Wang K, et al
    Two novel polymorphisms in PLCE1 are associated with the susceptibility to esophageal squamous cell carcinoma in Chinese population.
    Dis Esophagus. 2016 Apr 7. doi: 10.1111/dote.12463.
    PubMed     Text format     Abstract available


  147. KAMACHI K, Ozawa S, Hayashi T, Kazuno A, et al
    Impact of body mass index on postoperative complications and long-term survival in patients with esophageal squamous cell cancer.
    Dis Esophagus. 2016;29:229-35.
    PubMed     Text format     Abstract available


  148. SIMON M, Mal F, Perniceni T, Ferraz JM, et al
    Accuracy of staging laparoscopy in detecting peritoneal dissemination in patients with gastroesophageal adenocarcinoma.
    Dis Esophagus. 2016;29:236-40.
    PubMed     Text format     Abstract available


  149. RHEE K, Kim JH, Jung DH, Han JW, et al
    Self-expandable metal stents for malignant esophageal obstruction: a comparative study between extrinsic and intrinsic compression.
    Dis Esophagus. 2016;29:224-8.
    PubMed     Text format     Abstract available


  150. ZHAN L, Qin Q, Lu J, Liu J, et al
    Novel poly (ADP-ribose) polymerase inhibitor, AZD2281, enhances radiosensitivity of both normoxic and hypoxic esophageal squamous cancer cells.
    Dis Esophagus. 2016;29:215-23.
    PubMed     Text format     Abstract available


  151. TANG X, Fan Z, Wang Y, Ji G, et al
    Expression of klotho and beta-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
    Dis Esophagus. 2016;29:207-14.
    PubMed     Text format     Abstract available


    March 2016
  152. LIU F, Tian T, Xia LL, Ding Y, et al
    Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.
    Dis Esophagus. 2016 Mar 22. doi: 10.1111/dote.12489.
    PubMed     Text format     Abstract available


  153. MIYAWAKI Y, Nakajima Y, Kawada K, Okada T, et al
    Efficacy of docetaxel, cisplatin, and 5-fluorouracil chemotherapy for superficial esophageal squamous cell carcinoma.
    Dis Esophagus. 2016 Mar 22. doi: 10.1111/dote.12485.
    PubMed     Text format     Abstract available


  154. BABA Y, Baba H, Yamamoto S, Shimada H, et al
    Chemotherapy-induced nausea and vomiting is less controlled at delayed phase in patients with esophageal cancer: a prospective registration study by the CINV Study Group of Japan.
    Dis Esophagus. 2016 Mar 22. doi: 10.1111/dote.12482.
    PubMed     Text format     Abstract available


  155. HAGEN PV, Heijl MV, Henegouwen MI, Boellaard R, et al
    Prediction of disease-free survival using relative change in FDG-uptake early during neoadjuvant chemoradiotherapy for potentially curable esophageal cancer: A prospective cohort study.
    Dis Esophagus. 2016 Mar 22. doi: 10.1111/dote.12479.
    PubMed     Text format     Abstract available


    February 2016
  156. OPSTELTEN JL, de Wijkerslooth LR, Leenders M, Bac DJ, et al
    Variation in palliative care of esophageal cancer in clinical practice: factors associated with treatment decisions.
    Dis Esophagus. 2016 Feb 26. doi: 10.1111/dote.12478.
    PubMed     Text format     Abstract available


  157. PARRY K, Ruurda JP, van der Sluis PC, van Hillegersberg R, et al
    Current status of laparoscopic transhiatal esophagectomy for esophageal cancer patients: a systematic review of the literature.
    Dis Esophagus. 2016 Feb 26. doi: 10.1111/dote.12477.
    PubMed     Text format     Abstract available


  158. MATSUDA S, Tsubosa Y, Sato H, Takebayashi K, et al
    Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Dis Esophagus. 2016 Feb 26. doi: 10.1111/dote.12473.
    PubMed     Text format     Abstract available


  159. DU D, Song T, Liang X, Fang M, et al
    Concurrent chemoradiotherapy with elective lymph node irradiation for esophageal cancer: a systemic review and pooled analysis of the literature.
    Dis Esophagus. 2016 Feb 26. doi: 10.1111/dote.12471.
    PubMed     Text format     Abstract available


  160. TAN HZ, Lin WJ, Huang JQ, Dai M, et al
    Updated incidence rates and risk factors of esophageal cancer in Nan'ao Island, a coastal high-risk area in southern China.
    Dis Esophagus. 2016 Feb 26. doi: 10.1111/dote.12468.
    PubMed     Text format     Abstract available


  161. XU Y, Qiu M, Chen Y, Wang J, et al
    Long noncoding RNA, tissue differentiation-inducing nonprotein coding RNA is upregulated and promotes development of esophageal squamous cell carcinoma.
    Dis Esophagus. 2016 Feb 2. doi: 10.1111/dote.12436.
    PubMed     Text format     Abstract available


  162. YANG H, Wang J, Huang Q, Zheng Y, et al
    Intraoperative ultrasonography for the identification of thoracic recurrent laryngeal nerve lymph nodes in patients with esophageal cancer.
    Dis Esophagus. 2016;29:152-8.
    PubMed     Text format     Abstract available


  163. YIP C, Cook GJ, Landau DB, Davies A, et al
    Performance of different imaging modalities in assessment of response to neoadjuvant therapy in primary esophageal cancer.
    Dis Esophagus. 2016;29:116-30.
    PubMed     Text format    


  164. OTOWA Y, Nakamura T, Takiguchi G, Tomono A, et al
    Changes in modified Glasgow prognostic score after neoadjuvant chemotherapy is a prognostic factor in clinical stage II/III esophageal cancer.
    Dis Esophagus. 2016;29:146-51.
    PubMed     Text format     Abstract available


  165. GUO W, Ma L, Zhang Y, Ma X, et al
    Totally minimally invasive Ivor-Lewis esophagectomy with single-utility incision video-assisted thoracoscopic surgery for treatment of mid-lower esophageal cancer.
    Dis Esophagus. 2016;29:139-45.
    PubMed     Text format     Abstract available


  166. FUJIWARA H, Shiozaki A, Konishi H, Komatsu S, et al
    Hand-assisted laparoscopic transhiatal esophagectomy with a systematic procedure for en bloc infracarinal lymph node dissection.
    Dis Esophagus. 2016;29:131-8.
    PubMed     Text format     Abstract available


    January 2016
  167. LU Z, Wang J, Zheng Y, Yang S, et al
    Wild-type phosphatase and tensin homolog deleted on chromosome 10 improved the sensitivity of cells to rapamycin through regulating phosphorylation of Akt in esophageal squamous cell carcinoma.
    Dis Esophagus. 2016 Jan 3. doi: 10.1111/dote.12448.
    PubMed     Text format     Abstract available


  168. EIZAGUIRRE E, Larburu S, Asensio JI, Rodriguez A, et al
    Treatment of anastomotic leaks with metallic stent after esophagectomies.
    Dis Esophagus. 2016;29:86-92.
    PubMed     Text format     Abstract available


  169. WORMALD JC, Bennett J, van Leuven M, Lewis MP, et al
    Does the site of anastomosis for esophagectomy affect long-term quality of life?
    Dis Esophagus. 2016;29:93-8.
    PubMed     Text format     Abstract available


  170. SAHIN M, Ogut MF, Vardar R, Kirazli T, et al
    Novel esophageal speech therapy method in total laryngectomized patients: biofeedback by intraesophageal impedance.
    Dis Esophagus. 2016;29:41-7.
    PubMed     Text format     Abstract available


  171. XIE X, Luo KJ, Hu Y, Wang JY, et al
    Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer.
    Dis Esophagus. 2016;29:79-85.
    PubMed     Text format     Abstract available


  172. JIANG H, Cui Y, Ma K, Gong M, et al
    Experimental reconstruction of cervical esophageal defect with artificial esophagus made of polyurethane in a dog model.
    Dis Esophagus. 2016;29:62-9.
    PubMed     Text format     Abstract available


  173. WANG ZM, Kang YH, Yang X, Wang JF, et al
    Andrographolide radiosensitizes human esophageal cancer cell line ECA109 to radiation in vitro.
    Dis Esophagus. 2016;29:54-61.
    PubMed     Text format     Abstract available


    December 2015
  174. HORGAN AM, Darling G, Wong R, Guindi M, et al
    Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trial.
    Dis Esophagus. 2015 Dec 10. doi: 10.1111/dote.12444.
    PubMed     Text format     Abstract available


  175. DENG JY, Wang C, Shi XH, Jiang GL, et al
    Reduced toxicity with three-dimensional conformal radiotherapy or intensity-modulated radiotherapy compared with conventional two-dimensional radiotherapy for esophageal squamous cell carcinoma: a secondary analysis of data from four prospective clini
    Dis Esophagus. 2015 Dec 10. doi: 10.1111/dote.12435.
    PubMed     Text format     Abstract available


    May 2015
  176. REALDON S, Dassie E, Fassan M, Dall'Olmo L, et al
    In vivo molecular imaging of HER2 expression in a rat model of Barrett's esophagus adenocarcinoma.
    Dis Esophagus. 2015;28:394-403.
    PubMed     Text format     Abstract available


  177. ANTONOWICZ SS, Lorenzi B, Parker M, Tang CB, et al
    Annual computed tomography scans do not improve outcomes following esophagectomy for cancer: a 10-year UK experience.
    Dis Esophagus. 2015;28:365-70.
    PubMed     Text format     Abstract available


  178. VAN HAGEN P, Biermann K, Boers JE, Stoss O, et al
    Human epidermal growth factor receptor 2 overexpression and amplification in endoscopic biopsies and resection specimens in esophageal and junctional adenocarcinoma.
    Dis Esophagus. 2015;28:380-5.
    PubMed     Text format     Abstract available


  179. BOERWINKEL DF, Holz JA, Hawkins DM, Curvers WL, et al
    Fluorescence spectroscopy incorporated in an Optical Biopsy System for the detection of early neoplasia in Barrett's esophagus.
    Dis Esophagus. 2015;28:345-51.
    PubMed     Text format     Abstract available


  180. GUO J, Liu Z, Sun S, Liu X, et al
    Ligation-assisted endoscopic enucleation for treatment of esophageal subepithelial lesions originating from the muscularis propria: a preliminary study.
    Dis Esophagus. 2015;28:312-7.
    PubMed     Text format     Abstract available


  181. LEE YY, McColl KE
    Disruption of the gastroesophageal junction by central obesity and waist belt: role of raised intra-abdominal pressure.
    Dis Esophagus. 2015;28:318-25.
    PubMed     Text format     Abstract available


    April 2015
  182. PERRY C, Soomro I, Kaye P, Hardy E, et al
    Analysis of lymphatic and blood vessel invasion biomarkers in T1 esophagogastric adenocarcinomas for improved patient prognostication.
    Dis Esophagus. 2015;28:262-8.
    PubMed     Text format     Abstract available


  183. AHMAD J, Arthur K, Maxwell P, Kennedy A, et al
    A cross sectional study of p504s, CD133, and Twist expression in the esophageal metaplasia dysplasia adenocarcinoma sequence.
    Dis Esophagus. 2015;28:276-82.
    PubMed     Text format     Abstract available


  184. KHALAF N, Ramsey D, Kramer JR, El-Serag HB, et al
    Personal and family history of cancer and the risk of Barrett's esophagus in men.
    Dis Esophagus. 2015;28:283-90.
    PubMed     Text format     Abstract available


  185. KUMAGAI Y, Kawada K, Higashi M, Ishiguro T, et al
    Endocytoscopic observation of various esophageal lesions at x600: can nuclear abnormality be recognized?
    Dis Esophagus. 2015;28:269-75.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: